Proteasome inhibitors evoke latent tumor suppression programs in Pro-B MLL Leukemias through MLL-AF4.
Times cited: 14
Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival.
Biology of Blood and Marrow Transplantation.
Times cited: 16
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
Bone Marrow Transplantation.
Times cited: 1